Momentum Is Strong For Opus Genetics Inc (NASDAQ: IRD)

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Opus Genetics Inc is $34.09M. A total of 0.58 million shares were traded on the day, compared to an average of 189.83K shares.

In the most recent transaction, YERXA BENJAMIN R bought 10,000 shares of IRD for 0.98 per share on Nov 21 ’24. After the transaction, the President now owns 342,800 company shares. In a previous transaction on Nov 15 ’24, Magrath George bought 90,294 shares at 1.01 per share. IRD shares that Chief Executive Officer owns now total 483,244.

Among the insiders who bought shares, Magrath George acquired of 9,706 shares on Nov 18 ’24 at a per-share price of $1.02. This resulted in the Chief Executive Officer holding 492,950 shares of IRD after the transaction. In another insider transaction, Jayagopal Ashwath bought 3,500 shares at $1.76 per share on May 22 ’24. Company shares held by the Chief Scientific & Dev. Ofc. now total 78,500.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, IRD has a high of $3.40 and a low of $0.81.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. IRD’s latest balance sheet shows that the firm has $24.75M in Cash & Short Term Investments as of fiscal 2021. There were $538.00k in debt and $3.85M in liabilities at the time. Its Book Value Per Share was $1.31, while its Total Shareholder’s Equity was $22.22M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IRD is Buy with a score of 5.00.

Most Popular

Related Posts